MARKET

EOLS

EOLS

Evolus
NASDAQ
5.73
+0.10
+1.78%
After Hours: 5.70 -0.03 -0.52% 16:42 07/17 EDT
OPEN
5.53
PREV CLOSE
5.63
HIGH
5.79
LOW
5.52
VOLUME
457.99K
TURNOVER
--
52 WEEK HIGH
10.20
52 WEEK LOW
3.860
MARKET CAP
377.35M
P/E (TTM)
-8.5471
1D
5D
1M
3M
1Y
5Y
1D
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS)
TipRanks · 5d ago
Weekly Report: what happened at EOLS last week (0706-0710)?
Weekly Report · 6d ago
Evolus reports 115,000 RSU inducement grants to 38 new hires under 2023 plan
PUBT · 07/10 20:05
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
Barchart · 07/09 07:16
Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS)
TipRanks · 07/08 19:20
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)
TipRanks · 07/08 15:50
Evolus Secures U.S. Profhilo Distribution Agreement
TipRanks · 07/08 13:28
Evolus partners with IBSA to develop and market Profhilo in the U.S.
TipRanks · 07/08 13:10
More
About EOLS
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.